NCT00458302 - Treatment Simplification by Darunavir/Ritonavir 800/100 mg Once a Day Versus a Triple Combination Therapy With Darunavir/Ritonavir | Biotech Hunter

Enrollment

256

Participants

Timeline

Start Date

June 30, 2007

Primary Completion Date

February 28, 2009

Study Completion Date

January 31, 2011

Conditions

HIV InfectionsAIDS VirusHuman Immunodeficiency VirusAcquired Immunodeficiency Syndrome Virus

Interventions

DRUG

darunavir (DRV, TMC114)

800 mg qd (2 x 400 mg tablet) + 2 NRTI for 144 weeks

DRUG

darunavir (DRV, TMC114)

800 mg qd (2 x 400 mg tablet) monotherapy for 144 weeks

Trial Locations (27)

Vienna

Antwerp

Brussels

Aarhus

Copenhagen

Hvidovre

Odense

Berlin

Frankfurt

Hamburg

Hanover

Kÿln N/A

Budapest

Jerusalem

Tel Aviv

Tel Litwinsky

Lisbon

Porto

Moscow

Saint Petersburg

Barcelona

Donostia Guipuzcoa

Granada

Madrid

Valladolid

Sankt Gallen

London